QSAR analysis of substituted bis[(acridine-4-carboxamide)propyl]methylamines using optimized block-wise variable combination by particle swarm optimization for partial least squares modeling.
暂无分享,去创建一个
Wei-Qi Lin | Guo-Li Shen | Ru-Qin Yu | Jian-Hui Jiang | Jian-hui Jiang | G. Shen | R. Yu | Wei-Qi Lin | Li Lin | Li Lin
[1] C. Hansch,et al. Comparative QSAR studies on substituted bis-(acridines) and bis-(phenazines)-carboxamides: a new class of anticancer agents. , 2000, Bioorganic & medicinal chemistry.
[2] Lemont B. Kier,et al. The electrotopological state: structure information at the atomic level for molecular graphs , 1991, J. Chem. Inf. Comput. Sci..
[3] James P. Flynn,et al. Safe handling of chemical carcinogens, mutagens, teratogens, and highly toxic substances : by Douglas B. Walters (Ed.)., Ann Arbor Science Publishers, Inc., Ann Arbor, Michigan, 1980, 662 pp. in two volumes, £ 19.60 each volume , 1982 .
[4] Dennis K. J. Lin,et al. FORWARD SELECTION ERROR CONTROL IN THE ANALYSIS OF SUPERSATURATED DESIGNS , 1998 .
[5] Lemont B. Kier,et al. An Electrotopological-State Index for Atoms in Molecules , 1990, Pharmaceutical Research.
[6] Lemont B. Kier,et al. Electrotopological State Indices for Atom Types: A Novel Combination of Electronic, Topological, and Valence State Information , 1995, J. Chem. Inf. Comput. Sci..
[7] P. Lawson,et al. Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase II. , 1988, European journal of cancer & clinical oncology.
[8] L. Tenteromano,et al. Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer , 2004, Cancer Chemotherapy and Pharmacology.
[9] Brian T. Luke,et al. Evolutionary Programming Applied to the Development of Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..
[10] W. Denny,et al. Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. , 1987, Journal of medicinal chemistry.
[11] David Hartsough,et al. Toward an Optimal Procedure for Variable Selection and QSAR Model Building , 2001, J. Chem. Inf. Comput. Sci..
[12] Paul Geladi,et al. Interactive variable selection (IVS) for PLS. Part II: Chemical applications , 1995 .
[13] Claudio Agostinelli,et al. Robust stepwise regression , 2002 .
[14] Jian-hui Jiang,et al. Quantitative structure-activity relationships (QSAR): studies of inhibitors of tyrosine kinase. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[15] J. Gasteiger,et al. ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .
[16] Maurice Clerc,et al. The particle swarm - explosion, stability, and convergence in a multidimensional complex space , 2002, IEEE Trans. Evol. Comput..
[17] W. Wilson,et al. Characteristics of the interaction of anthrapyrazole anticancer agents with deoxyribonucleic acids: structural requirements for DNA binding, intercalation, and photosensitization. , 1988, Molecular pharmacology.
[18] K. Snow,et al. Multiple patterns of resistance of human leukemia cell sublines to amsacrine analogues. , 1990, Journal of the National Cancer Institute.
[19] L. P. Wakelin,et al. Polyfunctional DNA intercalating agents , 1986, Medicinal research reviews.
[20] Guo-Li Shen,et al. QSAR analysis of cyclooxygenase inhibitor using particle swarm optimization and multiple linear regression. , 2004, Journal of pharmaceutical and biomedical analysis.
[21] Paul Geladi,et al. Interactive variable selection (IVS) for PLS. Part 1: Theory and algorithms , 1994 .
[22] M. Dewar,et al. Ground States of Molecules. 38. The MNDO Method. Approximations and Parameters , 1977 .
[23] D. Scudiero,et al. Bisimidazoacridones and related compounds: new antineoplastic agents with high selectivity against colon tumors. , 1995, Journal of medicinal chemistry.
[24] Hugo Kubinyi,et al. Evolutionary variable selection in regression and PLS analyses , 1996 .
[25] Ru-Qin Yu,et al. Hybridized particle swarm algorithm for adaptive structure training of multilayer feed‐forward neural network: QSAR studies of bioactivity of organic compounds , 2004, J. Comput. Chem..
[26] H. Muss,et al. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix , 1992, Investigational New Drugs.
[27] W. Denny,et al. Potential antitumor agents. 44. Synthesis and antitumor activity of new classes of diacridines: importance of linker chain rigidity for DNA binding kinetics and biological activity. , 1985, Journal of medicinal chemistry.
[28] B. Roques,et al. Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cells. , 1984, Cancer research.
[29] C. Paoletti,et al. A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Robinson,et al. Bis-naphthalimides 3: synthesis and antitumor activity of N,N'-bis[2-(1,8-naphthalimido)-ethyl] alkanediamines. , 1996, Anti-cancer drug design.
[31] Yue Shi,et al. A modified particle swarm optimizer , 1998, 1998 IEEE International Conference on Evolutionary Computation Proceedings. IEEE World Congress on Computational Intelligence (Cat. No.98TH8360).
[32] A. Leo. CALCULATING LOG POCT FROM STRUCTURES , 1993 .
[33] Anton J. Hopfinger,et al. Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..
[34] Guo-Li Shen,et al. Modified particle swarm optimization algorithm for variable selection in MLR and PLS modeling: QSAR studies of antagonism of angiotensin II antagonists. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[35] R. Eberhart,et al. Fuzzy adaptive particle swarm optimization , 2001, Proceedings of the 2001 Congress on Evolutionary Computation (IEEE Cat. No.01TH8546).
[36] J. A. Spicer,et al. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents. , 1999, Journal of medicinal chemistry.
[37] Arup K. Ghose,et al. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics , 1989, J. Chem. Inf. Comput. Sci..
[38] M Pastor,et al. Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships. , 1997, Journal of medicinal chemistry.
[39] Svante Wold,et al. Hierarchical multiblock PLS and PC models for easier model interpretation and as an alternative to variable selection , 1996 .
[40] W. Denny. DNA-intercalating ligands as anti-cancer drugs: prospects for future design. , 1989, Anti-cancer drug design.
[41] G. Cruciani,et al. Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b. , 1994, Journal of medicinal chemistry.
[42] M. Pastor,et al. A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysis. , 1997, Journal of medicinal chemistry.
[43] Peter C. Jurs,et al. Automated Descriptor Selection for Quantitative Structure-Activity Relationships Using Generalized Simulated Annealing , 1995, J. Chem. Inf. Comput. Sci..
[44] E W Steyerberg,et al. Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. , 1999, Journal of clinical epidemiology.
[45] K. Paull,et al. In vitro assessment ofN-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistance , 2004, Cancer Chemotherapy and Pharmacology.
[46] Lemont B. Kier,et al. The Electrotopological State: An Atom Index for QSAR , 1991 .
[47] J. Riou,et al. From amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivatives. , 1996, European journal of cancer.
[48] O. H. Chan,et al. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions. , 2000, Journal of medicinal chemistry.
[49] P. Jurs,et al. Development and use of charged partial surface area structural descriptors in computer-assisted quantitative structure-property relationship studies , 1990 .
[50] Henry S. Rzepa,et al. Ground states of molecules: Part XLII. Vibrational frequencies of isotopically-substituted molecules calculated using MINDO/3 force constants , 1977 .
[51] W. Denny,et al. Potential antitumor agents. 35. Quantitative relationships between antitumor (L1210) potency and DNA binding for 4'-(9-acridinylamino)methanesulfon-m-anisidide analogues. , 1981, Journal of medicinal chemistry.
[52] B. Baguley,et al. Experimental solid tumour activity ofN-[2-(dimethylamino)ethyl]-acridine-4-carboxamide , 1995, Cancer Chemotherapy and Pharmacology.
[53] Riccardo Poli,et al. Particle swarm optimization , 1995, Swarm Intelligence.
[54] Jian-Hui Jiang,et al. Optimized Block-wise Variable Combination by Particle Swarm Optimization for Partial Least Squares Modeling in Quantitative Structure-Activity Relationship Studies , 2005, J. Chem. Inf. Model..
[55] Lemont B. Kier,et al. An index of electrotopological state for atoms in molecules , 1991 .